Liraglutide is a prescription injectable medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by mimicking the effects of GLP-1, a natural hormone that helps to regulate blood sugar levels and appetite.
Liraglutide has been shown to be very effective in lowering blood sugar levels and promoting weight loss. In clinical trials, liraglutide was shown to reduce A1C levels by up to 1.5%, and to help people lose an average of 5-10% of their body weight over the course of a year. Liraglutide has also been shown to reduce the risk of cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes.
Liraglutide is a once-daily injection, which makes it a convenient and easy-to-use medication. It is also generally well-tolerated, with the most common side effects being mild and temporary.